User profiles for Nicolás MS Gálvez
 | Nicolas MS Galvez ArriagadaRagon Institute of MGH, MIT and Harvard Verified email at mgh.harvard.edu Cited by 1794 |
[HTML][HTML] Neurologic alterations due to respiratory virus infections
K Bohmwald, NMS Gálvez, M Ríos… - Frontiers in cellular …, 2018 - frontiersin.org
Central Nervous System (CNS) infections are one of the most critical problems in public health,
as frequently patients exhibit neurologic sequelae. Usually, CNS pathologies are caused …
as frequently patients exhibit neurologic sequelae. Usually, CNS pathologies are caused …
Contribution of cytokines to tissue damage during human respiratory syncytial virus infection
K Bohmwald, NMS Gálvez… - Frontiers in …, 2019 - frontiersin.org
The human respiratory syncytial virus (hRSV) remains one of the leading pathogens causing
acute respiratory tract infections (ARTIs) in children younger than 2 years old, worldwide. …
acute respiratory tract infections (ARTIs) in children younger than 2 years old, worldwide. …
BCG vaccination induces cross-protective immunity against pathogenic microorganisms
JA Soto, NMS Gálvez, CA Andrade, MA Ramírez… - Trends in …, 2022 - cell.com
Bacillus Calmette-Guérin (BCG) is an attenuated Mycobacterium bovis strain used as a
vaccine to prevent Mycobacterium tuberculosis (M. tb) infection. Its ability to potentiate the …
vaccine to prevent Mycobacterium tuberculosis (M. tb) infection. Its ability to potentiate the …
Safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a subgroup of healthy adults in Chile
Background The development of effective vaccines against coronavirus disease 2019 is a
global priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (…
global priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (…
Recognition of variants of concern by antibodies and T cells induced by a SARS-CoV-2 inactivated vaccine
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible of the current pandemic ongoing all around the world. Since its discovery in 2019, …
responsible of the current pandemic ongoing all around the world. Since its discovery in 2019, …
A booster dose of CoronaVac increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern
CoronaVac is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization
(WHO). Previous studies reported increased levels of neutralizing antibodies and specific …
(WHO). Previous studies reported increased levels of neutralizing antibodies and specific …
Immune profile and clinical outcome of breakthrough cases after vaccination with an inactivated SARS-CoV-2 vaccine
Constant efforts to prevent infections by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are actively carried out around the world. Several vaccines are currently …
are actively carried out around the world. Several vaccines are currently …
[HTML][HTML] Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial
Background The ongoing COVID-19 pandemic has had a significant impact worldwide, with
an incommensurable social and economic burden. The rapid development of safe and …
an incommensurable social and economic burden. The rapid development of safe and …
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
…, C Orellana, C Covarrubias, NMS Gálvez… - …, 2023 - thelancet.com
Background The Omicron variant has challenged the control of the COVID-19 pandemic
due to its immuno-evasive properties. The administration of a booster dose of a SARS-CoV-2 …
due to its immuno-evasive properties. The administration of a booster dose of a SARS-CoV-2 …
SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study
…, A Barrera, P Castro, NMS Gálvez… - The Lancet Regional …, 2022 - thelancet.com
Background Solid-organ transplant (SOT) recipients have worse COVID-19 outcomes than
general population and effective immunisation in these patients is essential but more difficult …
general population and effective immunisation in these patients is essential but more difficult …
